Invest in Arcus Biosciences for a strong buying opportunity with promising data, robust pipeline, and significant market ...

Read here for more on the potential of RCUS's combination therapies for various cancers, with promising Phase 3 trials and ...

Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Iovance Biotherapeutics (IOVA – Research Report) today. The company’s ...

Precision BioSciences gains momentum as iECURE reports positive ECUR-506 data, and analysts forecast significant HBV ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Marcus Rashford has set Barcelona a deadline to finalise terms as he looks to secure a Manchester United exit, ...

Marcus Rashford, pushed out by Manchester United, is actively exploring his options during the winter transfer window. The ...

Is it just market speculation, or is there something more significant unfolding behind the scenes? At the core of Precision BioSciences’ sudden stock surge is the company’s gene-editing technology, ...

Shares of Precision BioSciences, Inc. (NASDAQ: DTIL) soared 60% following the announcement of a complete clinical response in the first infant dosed in a Phase 1/ ...

It looks like a UFO, or an alien ship, but these oddly-shaped clouds snapped by locals west of Brisbane on Thursday morning ...

BMO Capital Markets upgraded shares of Precision BioSciences (NASDAQ:DTIL – Free Report) from a market perform rating to an outperform rating in a report released on Friday, Marketbeat Ratings reports ...